Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





HEXACHLOROETHANE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 67-72-1; **Chemical Formula:** CCl3CCl3
OSHA’s current PEL for hexachloroethane is a 1-ppm TWA, with a skin notation, which was adopted from the 1968 ACGIH TLV. The NIOSH REL for this substance is the lowest feasible level, based on hexachloroethane’s potential carcinogenicity. Hexachloroethane is a nonflammable white solid.
The basis for the 1-ppm TLV was to prevent the “serious injury potential to several organ systems” shown by animal studies (ACGIH 1986/Ex. 1-3, p. 301). Subsequently, the ACGIH revised its TLV upward to 10 ppm based, in part, on a study by Weeks, Angerhofer, Bishop et al. (1979/Ex. 1-400) that reported no adverse effects among several animal species exposed daily to 15- or 48-ppm concentrations of hexachloroethane. The ACGIH also cited an NCI study (NCI 1978b/Ex. 1-949), in which “extremely heavy dosages...administered continuously for a long period of time” resulted in the development of hepatocellular tumors in mice but not in rats. The 10-ppm TLV was further supported by a personal communication of a TLV Committee member who reported that no ill effects occurred among workers “who handled the material with few precautions” during World War II (ACGIH 1986/Ex. 1-3, p. 301). No exposure data were supplied to support this personal communication.
In 1978, NIOSH reviewed the results of an NCI (1978b/Ex. 1-949) bioassay in which hexachloroethane was administered by gavage to mice and rats. Both male and female mice exhibited an excess incidence of hepatocellular carcinoma, but rats did not. NCI concluded that early mortality may have obscured detection of a carcinogenic effect in rats (NCI 1978b/ Ex. 1-949). Toxic kidney damage was also found in mice and rats treated with hexachloroethane. Based on this evidence, NIOSH (Chloroethanes: Review of Toxicity, Current Intelligence Bulletin 27, NIOSH 1978r) has recommended that exposure to hexachloroethane be maintained at the lowest detectable level.
Several participants (Exs. 3-678, 116, 144, and 194; Tr. pp. 9-149, 9-218) commented on hexachloroethane. The New Jersey Department of Health (Ex. 144) discussed the use of EPA’s IRIS system to determine limits (OSHA’s discussion of this approach is presented in Section VI.A of this preamble). The Workers Institute of Safety and Health (WISH)(Ex. 116; Tr. p. 9-218) and the AFL-CIO (Ex. 194) stated that the ACGIH’s increase in the limit for hexachloroethane reflects an inappropriate use of safety factors; WISH was also of the opinion that OSHA should have performed a quantitative risk assessment for hexachloroethane. In response to WISH, OSHA notes: (1) that the Agency is not following the ACGIH’s move to a higher limit for hexachloroethane; and (2) that OSHA performed risk assessments only for those substances classified in the carcinogen section of this preamble.
Lawrence Hecker, Corporate Director of Industrial Hygiene and Toxicology for Abbott Laboratories (Ex. 3-678; Tr. p. 9-1149) stated that the skin notation should not be retained for hexachloroethane because this material is not systemically toxic via dermal absorption. However, in accordance with the Agency’s policy on skin notations (see Section VI.C.18 of this preamble), OSHA is retaining a skin notation for hexachloroethane in the final rule.
OSHA concludes that the evidence relied on by the ACGIH is not adequate to support raising the PEL at this time. The human evidence cited by the ACGIH is anecdotal and lacks the exposure data necessary to permit OSHA to assess whether significant risk is absent (and likely to remain so) at the 10-ppm exposure level. In addition, OSHA is concerned, as is NIOSH (Ex. 8-47, Table N6A), about the development of tumors in hexachloroethane-exposed mice demonstrated in the NCI (1978b/Ex. 1-949) study. OSHA therefore retains its PEL of 1 ppm TWA, with a skin notation, and concludes that increasing the PEL for hexachloroethane would increase the significant risk of cancer potentially associated with exposure to this substance.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue